What should you know about prostate immunohistochemistry?

Prostate immunohistochemistry uses special stains on biopsy tissue to help identify cell features and clarify a diagnosis. A pathologist applies antibodies that attach to selected proteins in cells. The resulting colour pattern is examined with the tissue under a microscope. This can help distinguish prostate tissue from tissue arising elsewhere and can support the interpretation of cells that look unusual on routine staining. The stains are interpreted alongside the biopsy appearance, clinical history, examination findings, and imaging rather than as a stand-alone result.

A report may list marker names, whether staining is present or absent, and where the stain appears within the cell. A positive or negative result has meaning only in relation to the specific marker and the diagnostic question. One stain rarely settles the diagnosis by itself. The laboratory may use a panel of markers because different patterns provide a more reliable tissue profile. In prostate samples, this approach may help assess whether a small focus represents prostate cancer, a benign mimic, or a deposit from another organ. It may also help characterise a tumour when the routine microscopic appearance is not clear.

Immunohistochemistry is a laboratory method, not a separate operation and not a treatment. It is usually performed on tissue already collected during a biopsy or another procedure. Some tissue may be kept for additional stains, molecular tests, or review by another pathologist when that could clarify the findings.

Ask the clinician who arranged the biopsy to explain the overall pathology conclusion, not only individual marker names. Confirm whether the report identifies cancer, describes a suspicious or uncertain area, or supports a benign finding. Ask how the stain pattern fits with the biopsy grade, the number and location of sampled areas, prostate-specific antigen results, and any imaging. If the wording remains unclear, request a copy of the full report and ask whether a specialist pathology review is appropriate. Do not change medicines or make treatment decisions from an isolated immunohistochemistry line.

Contact the biopsy team promptly if you have fever, shaking chills, worsening pelvic pain, heavy bleeding, inability to pass urine, or feel suddenly unwell after the procedure. These symptoms need clinical assessment regardless of what the immunohistochemistry report says. Arrange follow-up for the pathology result even if you feel well, because the laboratory finding may require discussion, repeat testing, or a treatment-planning appointment. Bring the report and a list of medicines to that visit.

Which markers were tested, and what diagnostic question was each one intended to answer? Does the complete stain pattern support prostate cancer, a benign change, or another tissue origin? How certain is the pathology interpretation, and would a second review or further testing add useful information? How do the findings affect the next appointment, monitoring plan, or treatment discussion?